Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - CryoLife, Inc. (NYSE:CRY)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Recent Events
Aug  2Price hit new 52-week high ($44.82)
Location
1655 Roberts Boulevard N.W.
Kennesaw, GA 30144
Phone: (770) 419-3355
Fax: (770) 952-9743
Email: investorrelations@cryolife.com
Employees (last reported count): 340
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 600 SmallCap
Ownership
·Insider and 5%+ Owners: 27%
·Over the last 6 months:
 · 10 insider sells; 110.0K shares
  (2.1% of insider shares)
·Institutional: 54% (74% of float)
(175 institutions)
·Net Inst. Buying: 624.0K shares (+5.78%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
CryoLife, Inc. is engaged in the cryopreservation of viable human tissues for cardiovascular, vascular and orthopedic transplant applications, and develops and commercializes additional implantable products, including surgical bioadhesives. The Company develops and markets proprietary implantable biomaterials, including BioGlue surgical adhesive. Additionally, the Company develops bioprosthetic cardiovascular devices including two novel design stentless porcine heart valves marketed in the European Community. In November 2000, the Company received a Conformite Europeene (CE) Mark (product certification) for commercial distribution of its SynerGraft heart valve in the European Community. Domestically, the Company began applying its proprietary SynerGraft technology in February 2000 to enhance the preservation of human heart valves.
More from Market Guide: Expanded Business Description

Financial Summary
CryoLife, Inc. develops and commercializes technology for cryopreservation of viable human tissues for vascular, cardiovascular and orthopaedic transplant applications. For the six months ended 6/30/01, net revenues increased 10% to $43.1 million. Net income increased 40% to $5 million. Results reflect the growing acceptance of cryopreserved tissues and increased sales of BioGlue surgical adhesive. Results also reflect lower R&D expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Steven Anderson, 62
Chairman, Pres, CEO
$848K$396K
David Lee, 36
CFO, VP
--  --  
Albert Heacox, Ph.D., 50
Sr. VP - Laboratory Operations
260K1.3M
Sidney Ashmore, 42
VP of Marketing
--  --  
David Fronk, 37
VP, Clinical Research
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:CRYAs of 31-Aug-2001
Price and Volume
52-Week Low
on 1-Sep-2000
$17.375
Recent Price$35.77 
52-Week High
on 2-Aug-2001
$44.82 
Beta-0.26 
Daily Volume (3-month avg)135.4K
Daily Volume (10-day avg)203.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+103.4%
52-Week Change
relative to S&P500
+172.9%
Share-Related Items
Market Capitalization$673.0M
Shares Outstanding18.8M
Float13.7M
Dividends & Splits
Annual Dividendnone 
Last Split: 3 for 2 on 28-Dec-2000
Per-Share Data
Book Value (mrq)$5.06 
Earnings (ttm)$0.47 
Earnings (mrq)$0.13 
Sales (ttm)$4.15 
Cash (mrq)$1.99 
Valuation Ratios
Price/Book (mrq)7.07 
Price/Earnings (ttm)75.62 
Price/Sales (ttm)8.62 
Income Statements
Sales (ttm)$81.1M
EBITDA (ttm)$17.6M
Income available to common (ttm)$9.25M
Profitability
Profit Margin (ttm)11.4%
Operating Margin (ttm)16.8%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)8.34%
Return on Equity (ttm)10.32%
Financial Strength
Current Ratio (mrq)4.60 
Debt/Equity (mrq)0.15 
Total Cash (mrq)$37.3M
Short Interest
As of 8-Aug-2001
Shares Short526.0K
Percent of Float3.8%
Shares Short
(Prior Month)
450.0K
Short Ratio4.83 
Daily Volume109.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.